Masteroxyl 100 - Kalpa Pharmaceuticals

During its years of medical use, drostanolone propionate was primarily prescribed for postmenopausal women with breast cancer, offering a safer androgen alternative. Developed by Syntex and distributed by Eli Lilly, it was marketed under various names, including Drolban and Masteron. The compound’s non-estrogenic profile and mild side effect potential made it notable in both medicine and athletics. As prescription use declined, its value shifted toward performance enhancement, where it became known for supporting a dense, dry physique.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Masteroxyl 100 by Kalpa Pharmaceuticals, consult with your doctor or healthcare professional.